9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like Biotech Loses a Legend: Founder and Longtime CEO Dies at 71 May 14, 2017 Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017 Genentech Will Pass Out More Cash to Researchers to May 17, 2017
Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic December 12, 2017